Stock EDIT EDITAS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Market Closed - Nasdaq
Other stock markets
 01:30:00 03/07/2024 am IST 		5-day change 1st Jan Change
4.54 USD -1.52% Intraday chart for Editas Medicine, Inc. -8.65% -55.18%
14/06 Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial MT
14/06 Editas Medicine, Inc. Reports New Safety and Efficacy Data from the Rubber Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association Annual Congress CI
e0a3ff0e9fe5a4b71.kAY6kXvNiOhOpk2SxGsaljEQGjxaM_E7QCEsr0nxOIY.4GsD4i66594rxR-r9Q8vpmNHeXYKXLZyD1BN9wq3C9TdRAvFCZXA3iHHeQ~8855bf84d900d5ccb8901bdf80d41c97
  1. Stock Market
  2. Equities
  3. EDIT Stock
  4. Charts Editas Medicine, Inc.
  5. News Chart